Cho Hyuk Jin, Bae Woong Jin, Kim Su Jin, Hong Sung Hoo, Lee Ji Youl, Hwang Tae-Kon, Choi Yeong Jin, Hwang Sung Yeoun, Kim Sae Woong
Department of Urology, Seoul St. Mary's Hospital, The Catholic University of Korea, 505 Banpo-dong, Seocho-gu, Seoul, 137-040, Korea.
Urolithiasis. 2014 Aug;42(4):309-15. doi: 10.1007/s00240-014-0674-z. Epub 2014 Jun 29.
We investigated the effect of an ethanol extract of Lygodii spora (LS) as a preventive and therapeutic agent for experimentally induced calcium oxalate nephrolithiasis with ethylene glycol (EG) in rats. Male Wistar rats were randomly divided into preventive (n = 18, for 28 days) and therapeutic (n = 24, for 42 days) groups. The preventive group was further subdivided into three groups of six rats each: preventive control, preventive lithiatic control (EG) and preventive lithiatic LS (EG + 400 mg/kg LS). Similarly, the therapeutic group was subdivided into four groups of six rats each: therapeutic control, therapeutic lithiatic control, therapeutic lithiatic untreated, and therapeutic lithiatic LS. Lithiasis was induced by adding 0.75% EG to the drinking water of all groups except the preventive and therapeutic control groups. Preventive and therapeutic subjects also received the LS ethanol extract in drinking water at a dose of 400 mg/kg, since day 0 or day 28, respectively. At the end of the each experimental period, various biochemical parameters were measured in urine and kidney homogenates. The kidneys were subjected to histopathological analysis. The results revealed that treatment with the LS preventive protocol significantly decreased the levels of urinary calcium, oxalate and uric acid, and increased the levels of urinary citrate as compared to those in the EG control. No significant changes in the urinary parameters except oxalate and citrate levels were observed in the rats in the therapeutic protocol. In both preventive and therapeutic protocols, the extract significantly decreased kidney peroxides, renal calcium, oxalate content, and the number of kidney oxalate deposits as compared to those in the EG group. We conclude that LS is useful as a preventive and therapeutic agent against the formation of oxalate kidney stones.
我们研究了海金沙乙醇提取物(LS)作为预防和治疗剂对大鼠乙二醇(EG)诱导的草酸钙肾结石的作用。雄性Wistar大鼠被随机分为预防组(n = 18,为期28天)和治疗组(n = 24,为期42天)。预防组进一步细分为每组六只大鼠的三个组:预防对照组、预防结石对照组(EG)和预防结石LS组(EG + 400 mg/kg LS)。同样,治疗组细分为每组六只大鼠的四个组:治疗对照组、治疗结石对照组、治疗结石未治疗组和治疗结石LS组。除预防和治疗对照组外,所有组的饮用水中添加0.75% EG诱导结石形成。预防和治疗组的大鼠分别从第0天或第28天起,也在饮用水中接受400 mg/kg剂量的LS乙醇提取物。在每个实验期结束时,测量尿液和肾脏匀浆中的各种生化参数。对肾脏进行组织病理学分析。结果显示,与EG对照组相比,LS预防方案治疗显著降低了尿钙、草酸和尿酸水平,并增加了尿枸橼酸盐水平。在治疗方案中,除草酸和枸橼酸盐水平外,未观察到大鼠尿液参数有显著变化。在预防和治疗方案中,与EG组相比,提取物均显著降低了肾脏过氧化物、肾脏钙、草酸含量以及肾脏草酸沉积物的数量。我们得出结论,LS作为预防和治疗草酸肾结石形成的药物是有用的。